Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer

Recruiting now · Not applicable

Conditions studied: Pancreas Cancer

In brief

Specifically, in this project, the objective will be developped a model to capture imaging-based tumor heterogeneity with multiscale radiomics approach by obtaining the mirror tumor image at in vivo MRI, ex vivo MRI at histology. This imaging model giving a perfect virtual histology tumor representation will be secondary implemented on routine in vivo clinical MRI for early cancer detection and treatment monitoring. Successful completion of this proposal will lead to a comprehensive non invasive characterisation of pancreatic cancer and will be a game changer in patient management.

Key facts

Study ID

NCT06144762

Run by

Institut du Cancer de Montpellier - Val d'Aurelle

People needed

150

Starts

2023-12-19

Expected to finish

2029-10-01

Last updated by the study team

2025-02-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient aged >18 2.
• Pathologically proven pancreatic cancer which can beneficiate of upfront surgery or delayed surgery followed by neoadjuvant chemotherapy.
• Negative pregnancy test for women of childbearing potential
• Patients affiliated to a social protection system
• Written informed consent signed before project onset.

You may not qualify if…

• presence of metastases,
• Patient who will not have surgery
• Pregnant or breastfeeding women
• Mental or psychological state, physical or legal incapacity preventing participation in the project.

Where it is running

• NOUGARET Stephanie — Montpellier, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.